Key result
MicroRNA-765 overexpression reduces cardiomyocyte fractional shortening by ~35% via inhibitor-1 down-regulation.
Why the study?
Impaired SR Ca(2+) cycling and depressed contractility in heart failure are partially attributed to increased PP-1 activity and down-regulation of its inhibitor-1, but mechanisms mediating decreases in inhibitor-1 by post-transcriptional modification are unclear.
AIMS: Impaired sarcoplasmic reticulum (SR) Ca(2+) cycling and depressed contractility, a hallmark of human and experimental heart failure, has been partially attributed to increased protein phosphatase 1 (PP-1) activity, associated with down-regulation of its endogenous inhibitor-1. The levels and activity of inhibitor-1 are reduced in failing hearts, contributing to dephosphorylation and inactivation of key calcium cycling proteins. Therefore, we investigated the mechanisms that mediate decreases in inhibitor-1 by post-transcriptional modification. METHODS AND RESULTS: Bioinformatics revealed that 17 human microRNAs may serve as modulators of inhibitor-1. However, real-time PCR analysis identified only one of these microRNAs, miR-765, as being increased in human failing hearts concomitant with decreased inhibitor-1 levels. Expression of miR-765 in HEK293 cells or mouse ventricular myocytes confirmed suppression of inhibitor-1 levels through binding of this miR-765 to the 3'-untranslated region of inhibitor-1 mRNA. To determine the functional significance of miR-765 in Ca(2+) cycling, pri-miR-765 as well as a non-translated nucleotide sequence (miR-Ctrl) were expressed in adult mouse ventricular myocytes. The inhibitor-1 expression levels were decreased, accompanied by enhanced PP-1 activity in the miR-765 cardiomyocytes, and these reflected depressed contractile mechanics and Ca(2+) transients, compared with the miR-Ctrl group. The depressive effects were associated with decreases in the phosphorylation of phospholamban and SR Ca(2+) load. These miR-765 negative inotropic effects were abrogated in inhibitor-1-deficient cardiomyocytes, suggesting its apparent specificity for inhibitor-1. CONCLUSIONS: miR-765 levels are increased in human failing hearts. Such increases may contribute to depressed cardiac function through reduced inhibitor-1 expression and enhanced PP-1 activity, associated with reduced SR Ca(2+) load.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2015) studied Heart Failure (n=14). MicroRNA-765 (miR-765) vs. Control microRNA (miR-Ctrl) / Non-failing hearts was evaluated on Fractional shortening (FS%) under basal conditions in mouse cardiomyocytes. MicroRNA-765 expression is increased 2.3-fold in human failing hearts, and its experimental overexpression reduces cardiomyocyte fractional shortening by 35% through post-transcriptional down-regulation of inhibitor-1.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: